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Macrophage-Derived Metalloelastase
Is Responsible for the Generation
of Angiostatin in Lewis Lung Carcinoma
Zhongyun Dong, Rakesh Kumar, tumors is the macrophage. Macrophages play an essen-
tial role in homeostasis by participating in wound heal-Xiulan Yang, and Isaiah J. Fidler
Department of Cell Biology ing, chronic inflammatory reactions, tissue remodeling,
and host defense against neoplasms (Fidler, 1985,The University of Texas
M. D. Anderson Cancer Center 1994). During many of these processes, macrophages
degrade extracellular matrix proteins by secretion ofHouston, Texas 77030
matrix metalloproteinases (MMPs), which include inter-
stitial collagenase, stromelysin, type IV collagenases
(MMP-2 and MMP-9), and elastase (Shapiro et al.,1993a;
Summary Xie et al., 1994; Belaaouaj et al., 1995; Kumar et al.,
1996). Although the MMPs share certain biochemical
To determine the mechanism responsible for the in properties, each has a distinct substrate specificity (Ma-
vivo production of angiostatin that inhibits growth and trisian, 1992). Which of these enzymes the macrophage
metastasis in Lewis lung carcinoma (3LL), we im- produces depends on its level of differentiation and on
planted 3LL variant cells into thesubcutis of syngeneic tight regulation by many physiologic, pathologic, and
C57BL/6 mice. The tumors were infiltrated by macro- pharmacologic stimuli (Welgus et al., 1985; Busiek et
phages and expressed high levels of steady-state al., 1992; Lacraz et al., 1992; Xie et al., 1994; Kumar et
mRNA for metalloelastase (MME). Successive pas- al., 1996).
sages (more than three) of cultures established from In this report, we focus onthe elastases. The elastases
the tumors resulted in complete depletion of macro- can be divided into serine proteinases, which include
phages; steady-state MME mRNA, elastinolytic activ- pancreatic elastase (Shotton and Hartley, 1970) and
ity, and production of angiostatin (in the presence of neutrophil elastase (Ohlsson and Olsson, 1974), and the
plasminogen) were correspondingly reduced. Cocul- metalloelastase (MME) secreted by macrophages (Werb
ture of macrophages with either 3LL cells or their con- and Gordon, 1975). The substrates for elastase include
ditioned media containing granulocyte-macrophage type IV collagen, immunoglobulin, some glycoproteins
colony-stimulating factor resulted in secretion of MME such as a1-proteinase inhibitor, and elastin, but not gel-
and production of angiostatin by the macrophages, atin (Werb and Gordon, 1975; Banda et al., 1980; Banda
suggesting that angiostatin is produced by tumor-infil- and Werb, 1981; Banda et al., 1983). The genes coding
trating macrophages whose MME expression is stimu- for both MME and its human counterpart have been
lated by tumor cell±derived granulocyte-macrophage cloned and characterized (Shapiro et al., 1992, 1993b).
colony-stimulating factor. MME is essential for penetration of basement mem-
branes and tissue invasion by macrophages (Shipley et
al., 1996a), which can occupy up to 60% of the tumorIntroduction
mass (Normann, 1985; Whitworth et al., 1990; Bucana
et al., 1992; Mantovani et al., 1992). Since angiostatinThe resection of some primary neoplasms can lead to
can be generated in vitro from plasminogen by pancre-the accelerated growth of their distant metastases (Tyz-
atic elastase (O'Reilly et al., 1994), we hypothesizedzer, 1913; Sugarbaker et al., 1977; Gorelik et al., 1978,
that tumor-infiltrating macrophages can be induced to1980, 1981; Fisher et al., 1989). This accelerated growth
express MME, which in turn would generate angiostatinis independent of specific immune response (Prehn,
in vivo. The present study provides evidence to support1991, 1993) and has been termed ªconcomitant tumor
this hypothesis.resistance.º Studies have suggested a compelling ex-
planation for this phenomenon. O'Reilly et al. (1994)
reported that the plasma of mice bearing Lewis lung Results
carcinoma (3LL) contains an angiogenesis-inhibiting
substance named angiostatin that suppresses vascu- Resection of Local Subcutaneous Tumors
and Outgrowth of Lung Metastaseslarization and hence the growth of lung metastases.
Angiostatin is a 38 kDa fragment of plasminogen that In a first set of experiments, we determined whether the
excision of a local (primary) subcutaneous 3LL carci-selectively inhibits the proliferation of endothelial cells.
Several studies have produced results consistent with noma would enhance the growth of spontaneous lung
metastases. C57BL/6 mice were implanted subcutane-this model. After systemic administration, purified an-
giostatin can produce apoptosis in metastases (Holm- ously with cells from 3LL metastatic (3LL-met) or 3LL
nonmetastatic (3LL-nm) variants. Although the two vari-gren et al., 1995) and sustain the dormancy of several
human tumors implanted subcutaneously into nude ant lines had similar growth patterns in culture, the 3LL-
met produced rapidly growing tumors, and the 3LL-nmmice (O'Reilly et al., 1996). Although it is known that
angiostatin can be generated in vitro from plasminogen cells produced slow-growing tumors in the dorsal sub-
cutis of syngeneic mice. Specifically, the subcutaneousby digestion with pancreatic elastase (O'Reilly et al.,
1994), how it is generated in tumors remained unclear tumors reached 12±15 mm in diameter on days 14 and
28 for the 3LL-met and 3LL-nm cells, respectively. The(Fidler and Ellis, 1994).
One candidate mediator of angiostatin production in 3LL-nm tumors did not produce visible lung metastases
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Table 1. Enhanced Growth of Spontaneous 3LL Lung Metastases in Mice Subsequent to Resection of the Primary Subcutaneous
Tumor
Cell lines Lung metastases
Subcutaneous Lung weight
Assay Subcutaneous Intravenous tumor Median Range (mg, mean 6 SD)
Spontaneous lung
metastasis 3LL-nm Ð Sham surgery 0 Ð 200 6 16
Resected 0 Ð 205 6 18
3LL-met Ð Sham surgery 10 0±90 251 6 14
Resected 61a 34±145 474 6 29b
Experimental lung
metastasis Ð 3LL-met Ð 68 27±156 674 6 134
3LL-nm Ð Sham surgery 0 Ð 187 6 39
3LL-nm Ð Resected 0 Ð 177 6 6
3LL-nm 3LL-met Sham surgery 31a 14±81 276 6 15a
3LL-nm 3LL-met Resected 43 29±123 516 6 155
Spontaneous metastasis: C57BL/6 mice were injected subcutaneously (dorsal proximal midline) with 1 3 106 3LL cells (derived from subcutane-
ous tumors). When the tumors reached 12±15 mm in diameter (10±14 days for 3LL-met and 24±28 days for 3LL-nm cells), the mice were
anesthetized and the subcutaneous tumors were resected from one group of mice (n 5 10). The other group underwent sham surgery. The
mice were killed 2 weeks later.
Experimental metastasis: C57BL/6 mice were injected subcutaneously with 1 3 106 3LL-nm cells. When the tumors reached 10±12 mm in
diameter, the mice were anesthetized and the tumors were resected from one group of mice (n 5 20). The other group underwent sham
surgery. One day later, the mice were injected intravenously with 1 3 105 3LL-met cells. The mice were killed 3 weeks later. The lungs were
weighed and fixed in Bouin's solution, and spontaneous metastases were counted under a dissecting microscope.
a p . 0.05.
b p , 0.01.
regardless of whether the local subcutaneous tumor The 3LL-nm tumors also expressed a higher level of
MMP-9 than did the 3LL-met tumors. Neither 3LL-nmwas resected (even after 60 days). In contrast, on day
28 of the study, the 3LL-met subcutaneous tumors pro- nor 3LL-met cultures expressed MMP-9 transcripts (Fig-
ure 2). 3LL-nm and 3LL-met subcutaneous tumors ex-duced a median of 10 lung metastases in mice with
progressively growing subcutaneous tumors. In mice pressed similar levels of MMP-2 mRNAs, but only 3LL-
met cells expressed MMP-2 mRNA in culture (Figure 2).with resected subcutaneous tumor, the median number
of visible lung metastases was 61 (p . 0.05), and the
size of the lung metastases was significantly enhanced Expression of MME and Generation of Angiostatin
Since pancreatic elastase has been shown to cleave(p , 0.01) (Table 1). These results show that the surgical
resection of a metastatic variant of the 3LL tumor signifi- plasminogen to fragments that include angiostatin
(O'Reilly et al., 1994), we next determined whether thecantly enhances the size of spontaneous lung metas-
tases. MME in the 3LL tumors is associated with generation
of angiostatin activity. Cells isolated by enzymatic disso-In a second set of experiments, we implanted 3LL-nm
cells subcutaneously into syngeneic mice. When the ciation of 3LL-met tumors were cultured. Immediately
after dissociation and after varying numbers of pas-tumors reached 10±12 mm in diameter, the mice under-
went resection of the lesion or sham surgery. One day sages in culture to deplete macrophages, we assessed
macrophage content (immunohistochemistry staining),later, the mice (n 5 10) received 3LL-met cells intrave-
nously. The subcutaneous tumor significantly sup- MME mRNA (Northern blotting), MME activity in the cul-
ture supernatant (enzymatic assay), and generation ofpressed (p , 0.05) the growth of experimental lung me-
tastases (Table 1). angiostatin subsequent to the addition of plasminogen
(bioassay).
The data shown in Figure 3 demonstrate that, withMacrophage Infiltration into Subcutaneous
Tumors and Expression of MMPs increasing passage number, the number (content) of
macrophages decreased, and after three passages inImmunohistochemistry staining of cryostat sections us-
ing murine macrophage-specific antibody F4/80 re- vitro, we found no evidence of macrophages among the
3LL cells (Figure 3A). The level of MME transcript (Figurevealed that both 3LL-nm and 3LL-met subcutaneous
tumors were infiltrated by macrophages. The density in 3B) and elastase activity (Figure 3C) directly correlated
with the number of macrophages in the cultures. Humanthe 3LL-nm tumors was greater (compare Figures 1C
and 1D). plasminogen was added to the cultures, at different pas-
sages. The supernatant fluids were recovered 72 hr laterWe next examined the expression of MMPs in the
3LL subcutaneous tumors and their cultured cells. High and tested for angiostatin activity. The highest angio-
statin activity was found in cultures containing the high-levels of MME mRNA were detected in both 3LL-nm and
3LL-met tumor tissues; low levels were detected in the est number of macrophages (immediate cultures, pas-
sage 0) and declined with increasing passage number.3LL cells cultured in vitro. Correlated with the extent of
macrophage infiltration, the 3LL-nm tumors expressed No angiostatin activity was found in cultures depleted
of macrophages or in the absence of plasminogen (Fig-a significantly higher level of MME mRNA than did the
3LL-met tumors (Figure 2). ure 3D). The angiostatin activity (antiproliferation) was
Generation of Angiostatin by Macrophages
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Figure 1. Macrophage Infiltration in 3LL
Tumors
Subcutaneous tumors (8±10 mm in diameter)
were resected. Tumor samples were fixed in
formalin for hematoxylin and eosin (H & E)
staining (A and B) or in liquid nitrogen for
immunohistochemical staining using anti-
body against F4/80 antigen (C and D).
specific for theendothelial cells: it did not inhibit division and the macrophages, but not from pancreatic elastase,
was completely suppressed by the MMP inhibitor 1,10-of 3LL cells, B16 melanoma cells, or NIH-3T3 cells (data
not shown), agreeing with results from a published re- phenanthraline.
port (O'Reilly et al., 1994).
The elastinolytic activity detected in the 3LL-met tu- Secretion of Elastase and Generation
of Angiostatin in Cocultures of 3LLmor was an MME. We base this conclusion on the results
of experiments using various selective proteinase inhibi- Cells and Macrophages
To determine whether 3LL cells can regulate elastasetors (Figure 3E). At 10 mM, the serine proteinase inhibitor
phenylmethylsulfonyl fluoride produced greater than activity and hence regulate the production of angiostatin
in macrophages, we next cultured purified peritoneal80% inhibition of pancreatic serine elastase activity, but
it did not inhibit the elastinolytic activity from the 3LL exudate macrophages in serum-free medium with or
without 3LL-met or 3LL-nm cells in the absence (Figuretumor tissue or from purified cultures of macrophages.
In contrast, elastase activity from both the tumor tissue 4A) or presence (Figure 4B) of plasminogen. In agree-
ment with a previous report (Werb and Gordon, 1975),
the inflammatory macrophages constitutively secreted
elastase (Figure 4A) and expressed MME mRNA, as de-
termined by Northern blot analysis (data not shown). A
detectable (baseline) level of elastinolytic activity was
detected inculture supernatants of 3LL-met and 3LL-nm
cells. Since the 3LL cells did not express MME mRNA,
we attribute the elastinolytic activity to other proteases
released by the tumor cells. Supernatants of macro-
phage-3LL cocultures contained elastinolytic activity
3-fold higher than that of supernatants harvested from
macrophages cultured alone (Figure 4A). In parallel ex-
periments, we added plasminogen to the macrophages
cultured alone, 3LL cells cultured alone, or macrophage-
3LL cocultures. Angiostatin activity (inhibition of endo-
thelial cell proliferation) directly correlated with elastino-
lytic activity: macrophages cultured alone produced24%
inhibition of endothelial cell growth, whereas macro-
phages cultured with 3LL cells produced 43%±46% inhi-
bition of endothelial cell growth. The angiostatin activity
in supernatants of 3LL cells cultured alone was less thanFigure 2. Northern Blot Analyses of MMP Gene Expression in 3LL
Tumors and Their Cultures 4% (Figure 4B).
Polyadenylated mRNA (1 mg/lane) from subcutaneous tumors (T) or To verify that the inhibition of endothelial cell prolifera-
their tissue cultures (more than three passages) (C) was separated, tion was due to angiostatin, we identified this 38 kDa
blotted, and probed with cDNA fragments specific for MMP-2, fragment of plasminogen (O'Reilly et al., 1994) by immu-
MMP-9,MME, and GAPDH.The resultsof densitometric quantitation
noblotting with a monoclonal antibody against lysine-of the transcripts, performed as described in Experimental Proce-
binding site 1 (LBS-1). Consistent with the bioassaydures, are shown under each band. Values are the ratio of the aver-
(Figure 4B), the 38-kDa fragment was found in the super-age area of the proteinase transcripts to that of the GAPDH tran-
script. natant of the macrophage-3LL cocultures incubated in
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Figure 3. Macrophages Expressed MME and Generated Angiostatin in 3LL-met Subcutaneous Tumor Cells
Cells from subcutaneous 3LL-met tumors were recultured and passaged successively in vitro. Pn, passage number. (A) Macrophage (Mù)
content, (B) MME mRNA expression, (C) MME activity, and (D) angiostatin activity from each passage of the samples were analyzed as
described in Experimental Procedures. Plg, plasminogen. (E) The elastinolytic activity was demonstrated to be MME through the use of several
specific inhibitors. PMSF, phenylmethylsulfonyl fluoride.
*p , 0.05.
medium plus plasminogen and, to a lesser extent, in the plasminogen. Elastinolytic and angiostatin activities
were then determined (Figure 6A). To demonstrate thatsupernatants of macrophages incubated alone in me-
dium containing plasminogen butnot inculture superna- MME activity was essential for the production of angio-
statin, we incubated medium from macrophage culturestants from 3LL-met cells incubated in medium plus plas-
minogen (Figure 5A). Moreover, the angiostatin activity pretreated with supernatants of 3LL-met cells with hu-
man plasminogen in the absence or presence of thewas neutralized by theantibody against LBS-1 in a dose-
dependent manner (Figure 5B). Subsequent to separa- MME inhibitor ethylene diamine tetraacetic acid (EDTA)
(Kumar et al., 1996). Subsequent to dialysis, we foundtion by fast protein liquid chromatography (FPLC) (with
a Superdex-200 column), the angiostatin activity ap- that EDTA completely blocked the generation of angio-
statin activity. However, EDTA addedto themacrophagepeared in the fractions with an apparent mass of approx-
imately 40 kDa and reacted with the antibody to LBS-1 supernatants after incubation with human plasminogen
did not prevent or inhibit the generation of angiostatinin a Western blot analysis (Figure 5C).
To ascertain that the increased generation of angio- activity (Figure 6B, far right bar). The generation of angio-
statin activity was dependent on the concentration ofstatin in the 3LL macrophage cocultures was due to
macrophage-derived MME, we next incubated macro- plasminogen, reaching a peak at 100 mg/ml (Figure 6C).
Similarly, the inhibition of endothelial cell proliferationphages in medium (control) or medium conditioned by
3LL-met cells in the presence or absence of human by angiostatin was dose dependent (Figure 6D).
Generation of Angiostatin by Macrophages
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Figure 4. 3LL Tumor Cells Increased MME Secretion and Angio-
statin Production by Macrophages
Purified mouse PEM (Mù), 3LL-nm, or 3LL-met cells were cultured
in MEM±5% FBS separately or in combination for 24 hr. The cultures
were rinsed briefly and incubated in serum-free DMEM/F12 medium
for 72 hr in the absence (A) or presence (B) of human plasminogen.
MME (A) and angiostatin (B) activities in the supernatants were
determined.
Granulocyte-Macrophage Colony-Stimulating
Factor Released by 3LL Cells Is Responsible Figure 5. Identification of Angiostatin
for Increased Secretion of MME
(A) Identification of a 38 kDa plasminogen fragment in the condi-
by Macrophages tioned medium of macrophages and 3LL-met cultures. Human plas-
Granulocyte-macrophage colony-stimulating factor (GM- minogen (lane 1) and purified angiostatin (lane 2) served as controls.
The supernatants (50 mg/lane) of macrophages plus plasminogenCSF) is the only cytokine (among many examined) that
(lane 3), macrophages and 3LL-met plus plasminogen (lane 4), orcan up-regulate MME expression in murine macro-
3LL-met plus plasminogen (lane 5) were separated by 10% SDSphages (Kumar et al., 1996). Therefore we next deter-
polyacrylamide gel electrophoresis, blotted, and probed using a
mined whether 3LL cells produced and released GM- monoclonal antibody against plasminogen LBS-1.
CSF and whether it in turn increased elastinolytic activity (B) Neutralization of angiostatin activity by an antibody to LBS-1.
in macrophages and hence the production of angio- The angiostatin assay was conducted in the presence of anti-LBS-1
or an equivalent amount of control IgG. CTR, control.statin. Reverse transcriptase±polymerase chain reac-
(C) FPLC analysis. The sample was separated in a Superdex-200tion (RT-PCR) analysis showed the presence of GM-
column using PBS as an eluent. After dialysis against DMEM, angio-CSF mRNA in both the 3LL-nm and 3LL-met variants
statin activity was assessed in the bioassay and identified by West-growing in culture (data not shown). Similar levels of
ern blot (WB) analysis using anti-Plg-LBS-1 antibody. Arrows indi-
steady-state GM-CSF mRNA were also found in thesub- cate LBS-1.
cutaneous tumors (data not shown). Culture superna-
tants of 3LL-met and 3LL-nm variants contained 28 and
40 pg of GM-CSF, respectively, per 106 cells/72 hr. Fur- activity (Figure 6F). Neither the anti-GM-CSF antibody
nor the nonspecific IgG affected the generation of MMEther evidence of the role of GM-CSF (released by 3LL
cells) in the regulation of MME and production of angio- or angiostatin activity in macrophages incubated in me-
dium alone.statin activity came from neutralization experiments
(Figures 6E and 6F). Murine macrophages were incu-
bated with medium (control) or medium conditioned by Expression of MMP-9 Is Not Required
for Production of Angiostatin3LL-nm or 3LL-met cells in the absence of presence of
antibodies against mouse GM-CSF or control-nonspe- MMP-9 is constitutively released from murine macro-
phages, and its secretion can be increased by a varietycific immunoglobulin G (IgG). Antibodies against GM-
CSF but not those against IgG significantly decreased of stimuli (Xie et al., 1994). Since MMP-9 has some elas-
tinolytic activity (Senior et al., 1991), we wished to deter-the production of elastase (Figure 6E) and angiostatin
Cell
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Figure 6. Increased Macrophage MME Se-
cretion and Angiostatin Production by Me-
dium of 3LL Cells
(A) Purified mouse PEM were incubated for 24
hr in MEM containing 5% FBS or conditioned
media of 3LL-nm or 3LL-met. The cells were
rinsed and cultured for 72 hr in serum-free
DMEM/F12 in the absence (left) or presence
(right) of human plasminogen. MME (left) and
angiostatin (right) activities in the superna-
tants were then determined.
(B) Macrophages (Mù) were incubated for 3
days in serum-free supernatants of 3LL-met
cells. The macrophage-conditioned medium
(Mù CM) was then incubated for another 3
days with 100 mg/ml plasminogen (Plg) in the
absence or presence of 5 mM EDTA. EDTA
added to the medium after the incubation (far
right bar) served as a control. The mixtures
were dialyzed, and angiostatin activity was
determined.
(C) Production of angiostatin is dose depen-
dent on the concentration of human plas-
minogen.
(D) Suppression of endothelial cell growth is
dependent on the concentration of angio-
statin (dilution of macrophage-conditioned
medium plus human plasminogen).
(E and F) Stimulation of MME secretion
and angiostatin production by 3LL cell±con-
ditioned medium was blocked by GM-CSF
antibody. The conditioned medium of 3LL
cells were incubated with 20 mg/ml GM-CSF
antibody or the same concentration of rat IgG
for 45 min at 378C and then used to treat
macrophages as described for (A). MME (E)
and angiostatin (F) activities in the superna-
tants were then determined. *p , 0.05.
mine whether it contributed to the generation of angio- Discussion
statin in the 3LL carcinoma±macrophage system. We
therefore cultured macrophages in medium alone (con- Our data confirm earlier reports that the resection of a
trol) or medium containing 1 mg/ml lipopolysaccharide subcutaneous (primary) metastatic 3LL carcinoma line,
(LPS) or 1000 U/ml GM-CSF in the absence (for enzyme 3LL-met, is associated with accelerated growth of spon-
assays) or presence (for production of angiostatin) of taneous lung metastases (Gorelik, 1983a, 1983b). In ad-
200 mg/ml plasminogen. As shown in Table 2, while dition, we show that intact subcutaneous 3LL-nm tumor
LPS increased the secretion of MMP-9, it decreased the (but not a resected lesion) suppressed the growth of
release of MME. Incubation of macrophages with GM- experimental lung metastases produced by the intrave-
CSF enhanced the secretion of MME without affecting nous injection of 3LL-met cells. O'Reilly et al. (1994)
the levels of MMP-9. Since generation of angiostatin recently showed that this is due toa decrease in circulat-
was suppressed by LPS and augmented by GM-CSF, ingangiostatin. Our results demonstrate that thegenera-
we conclude that MME, and not MMP-9, was responsi- tion of angiostatin by the subcutaneous tumors requires
ble for the generation of angiostatin by macrophages the presence of macrophages and is directly correlated
(Table 2). with their metalloelastinolytic activity. The addition of
plasminogen to 3LL cells cultured in vitro did not result
in generation of angiostatin, whereas the addition of
Table 2. Correlation of MME and MMP-9 Production by
plasminogen to cocultures of macrophages and 3LLMacrophages with Generation of Angiostatin
cells did. Elastase activity in macrophages was up-regu-
Macrophage Elastase MMP-9 Angiostatin lated by the cytokine GM-CSF. Indeed, GM-CSF se-
Treatment Activity Activity Activity
creted by 3LL cells significantly enhanced the produc-
Medium 37.0 6 2.9 193 22.2 6 4.8 tion of elastase by macrophages and hence the
LPS 6.5 6 2.6 389 8.9 6 7.1 generation of angiostatin from plasminogen. Although
GM-CSF 108.0 6 7.5 201 43.7 6 1.8
our data lead us to conclude that MME released from
a MME activity (counts per minute 3 103 per reaction). tumor-infiltrating macrophages is responsible for the
b Zymography (densitometry units). angiostatin production by 3LL tumors, they do not ex-
c Angiostatin activity (percentage inhibition of BCE growth).
clude the existence of other enzymatic activity, such as
Generation of Angiostatin by Macrophages
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that of serine proteases (Gately et al., 1996), that can cytokines such as interleukin-1 or interleukin-6 (Takeda
et al., 1991a), and lung metastases from some murinealso produce angiostatin.
The degradation of plasminogen to angiostatin is me- tumor cells can produce GM-CSF (Takeda et al., 1991b;
Young et al., 1992).diated by elastase (O'Reilly et al., 1994). Since MMP-2
and MMP-9 also have elastinolytic activity (Senior et al., We recently identified GM-CSF as the cytokine that
can up-regulate MME expression in murine macro-1991; Katsuda et al., 1994; Shipley et al., 1996b), we
determined whether the expression of these proteases phages (Kumar et al., 1996). The present data suggest
that GM-CSF produced by 3LL-nm and 3LL-met tumorsby 3LL cells could have contributed to the generation
in vivo of angiostatin. From the following data, we con- enhances the expression by macrophages of MME,
which is responsible for the generation of angiostatinclude that they did not. First, the metastatic 3LL-met
cells expressed higher levels of MMP-2 than did the and hence growth suppression of lung metastases. This
conclusion is based on the following data. First, 3LLlow-metastatic 3LL-nm cells, yet neither generated an-
giostatin activity. Second, the 3LL-nm tumors in vivo cells (in tumors and in culture) constitutively expressed
GM-CSF. Second, GM-CSF stimulated MME secretion(consisting of tumor cells and infiltrating macrophages)
expressed low levels of MMP-2 yet were able to gener- and the production of angiostatin activity by macro-
phages. Third, the stimulatory effects of the 3LL-condi-ate angiostatin activity. Third, incubation of macro-
phages with LPS stimulated the release of MMP-9 and tioned medium on macrophage secretion of MME and
production of angiostatin was significantly inhibited bysuppressed the release of MME. The production of
angiostatin was significantly reduced by LPS-treated antibody against GM-CSF. Therefore, while GM-CSF
may play a role in the establishment of metastasismacrophages. Finally, generation of angiostatin by macro-
phages was augmented by GM-CSF, which increased (Takeda et al., 1991b; Young et al., 1992), it can also
suppress the development of a blood supply to thesethe expression of MME and did not affect MMP-9. The
reason for the difference between MME and MMP-2 or lesions. It is likely that GM-CSF has different targets
for mediating these two seemingly opposing processes.MMP-9 in the generation of angiostatin is not clear. It
may be due to a differential affinity of these MMPs for Formation of experimental lung metastasis has been
shown to be increased simply by pretreatment of tumorplasminogen. Alternatively, the levels of MMP-2 and
MMP-9 in our system may not have been high enough cells with GM-CSF (Young et al., 1992). The production
of angiostatin, however, requires the participation ofto produce the amount of angiostatin that can be de-
tected in the bioassay. macrophages and the presence of plasminogen.
The interaction of macrophages with tumor cells pro-The growth and metastasis of tumor cells are depen-
dent on the cells' interaction with host homeostatic foundly affects their growth and metastasis. Whereas
activated tumoricidal macrophages can selectively lysemechanisms that include factors released by specific
organ microenvironments (Fidler, 1990, 1995). Indeed, tumor cells (Fidler, 1985, 1994; Fidler and Schroit, 1988),
nonactivated macrophages actually enhance tumorthe phenotype of tumor-infiltrating macrophages has
been shown to differ among tumors growing in different growth by producing growth factors (Nathan, 1987), an-
giogenic factors (Polverini, 1989), and proteases (Xie etorgans (Normann, 1985). Although most tumors are infil-
trated by macrophages (Talmadge et al., 1981; Whit- al., 1994). These findings may explain in part why the
systemic administration of relatively specific macro-worth et al., 1990; Bucana et al., 1992; Mantovani et al.,
1992), accelerated growth of metastases subsequent to phage toxins, such as silica, carrageenan, and trypan
blue, reduces the size of local (primary) murine tumorsresection of a primary tumor has been observed in only
some systems (Gorelik, 1983a, 1983b; O'Reilly et al., but enhances the growth of metastases (Jones and Cas-
tro, 1977; Mantovani et al., 1980; Keller, 1982; Mantovani1994).
To produce clinically relevant metastasis, tumor cells et al., 1992).
must complete a long series of interlinked selective In conclusion, we show that the production of angio-
steps (Poste and Fidler, 1980). Since failure to complete statin by 3LL tumors growing subcutaneously is associ-
even one of the steps aborts the process, the failure to ated with the up-regulation of MME in the infiltrating
produce metastasis may be due to different deficiencies macrophages. The involvement of macrophages in the
(Aukerman et al., 1986). We found that both 3LL-nm and control of angiogenesis suggests their role in other pro-
3LL-met cells could stimulate the generation of angio- cesses, such as wound healing and organ repair from
statin by macrophages. Nevertheless, the resection of injury (Whitworth et al., 1990). Since MME expression
3LL-nm tumors did not lead to an increase in thenumber in macrophages is enhanced by GM-CSF, the role of
or size of lung metastases. The failure of 3LL-nm cells this cytokine in the generation of angiostatin and hence
to metastasize was due not to any angiostatin effect, control of metastasis is under current investigation.
but rather to some other deficiency, such as in MMP-2,
that led to failure to invade. In that case, the issue of Experimental Procedures
inhibition of blood vessel formation in the lung is not
Micerelevant.
Specific, pathogen-free female C57BL/6 mice were purchased fromTumor cells that produce metastases in specific or-
Jackson Laboratory (Bar Harbor, ME). The mice were maintained
gans can produce cytokines that stimulate the organ according to institutional guidelines under specific pathogen-free
environment to support the growth of the tumor cells conditions in facilities approved by the American Association for
(Fidler, 1995). For example, tumor cells in liver metasta- Accreditation of Laboratory Animal Care and in accordance with
current regulations and standards of the Department of Agriculture,ses can produce high levels of hepatocyte-activating
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Department of Health and Human Services, and the National Institutes To demonstrate that MME was responsible for the generation of
angiostatin activity, we incubated medium conditioned by macro-of Health. The mice were used when they were 8±12 weeks old.
phages (after their treatment with supernatants of 3LL cells) with
human plasminogen in the absence or presence of 5 mM EDTA.Cell Culture
Subsequent to dialysis (to remove the EDTA), angiostatin activityThe nonmetastatic variant 3LL-nm was isolated from a 3LL tumor
(assessed as antiproliferation of endothelial cells) was determined.originally obtained from the National Cancer Institute Tumor Bank
(National Cancer Institute±Frederick Cancer Research Facility, Fred-
erick, MD) (Talmadge and Fidler, 1982). The metastatic variant 3LL- Elastase Assay
met was obtained from Dr. M. O'Reilly (Harvard Medical School, Elastase activity in the conditioned medium was determined by a
Boston, MA) (O'Reilly et al., 1994). Both tumor cell lines were main- method described previously using [3H]NaBH4-reduced elastin as a
tained in tissue culture in Eagle's minimal essential medium (MEM) substrate (Werb et al., 1986). The samples were mixed in reaction
supplemented with 10% fetal bovine serum (FBS), sodium pyruvate, buffer (100 mM Tris/HCl, 5 mM CaCl2, 0.2 mg/ml sodium dodecyl
nonessential amino acids, L-glutamine, and a 2-fold vitamin solution. sulfate (SDS), and 0.006% NaH3) and incubated at a concentration
Adherent cultures were maintained on plastic and were incubated of 600 mg/ml at 378C for 16 hr. Free-form 3H release was monitored,
in 5% CO2±95% air at 378C. The cultures were free of mycoplasma and the enzyme activity was expressed as counts per minute per
and pathogenic mouse viruses. Prior to the studies, both cell lines reaction.
were injected subcutaneously into syngeneic C57BL/6 mice. Cul-
tures were established as described below. Immunohistochemistry
Bovine capillary endothelial cells (BCE) obtained from Dr. O'Reilly Macrophages in 3LL tumors or in cultures established from these
(Harvard Medical School) were cultured on gelatinized surfaces in tumors were identified by immunohistochemistry using the macro-
Dulbecco's minimal essential medium (DMEM)±10% calf serum sup- phage-specific F4/80 antibody (Austyn and Gordon, 1981). Sections
plemented with 3 ng/ml human basic fibroblast growth factor (Gen- (8±10 mm) of frozen tumor tissue or cultured cells fixed with 0.125%
zyme, Cambridge, MA) in 10% C02 (O'Reilly et al., 1994). glutaraldehyde in phosphate-bufferedsaline (PBS) were treated with
a rat monoclonal F4/80 antibody followed by gold-labeled second-
Animal Studies ary antibody as described in detail previously (Bucana et al., 1992).
Subcutaneous tumors (8±12 mm in diameter) were resected asep-
tically. All necrotic zones were removed, and the viable tissue was
Angiostatin Assay
minced and dissociated with collagenase (type I, 200 U/ml) and
Angiostatin activity, assessed as inhibition of BCE proliferation, was
DNase (270 U/ml) (Sigma, St. Louis, MO) as described previously
determined as described previously (O'Reilly et al., 1994). In brief,
(Dong et al., 1994). Cells were suspended in MEM containing 10%
BCE were seeded onto gelatinized 24-well plates at 1.25 3 104/well/
FBS and plated at 5±10 3 106 viable cells/T150 flask. After a 3 hr
0.5 ml DMEM±10% calf serum, allowed to adhere overnight, rinsed,adherence, the cultures were rinsed and given fresh medium. Forty-
and incubated with 0.25 ml/well DMEM±5% calf serum or test sam-eight hours later, the adherent tumor cells were harvested by brief
ples for 20 min. Additional medium containing basic fibroblasttrypsinization, washed in MEM±10% FBS, and resuspended in
growth factor was then added to a final concentration of 1 ng/mlHanks' balanced salt solution (HBSS). Aliquots of 106 cells in 0.1 ml of
at 0.5 ml/well. Seventy-two hours later, the cells were harvested by
HBSS were injected into the dorsal subcutis in the proximal midline.
trypsinization and counted. Angiostatin activity was expressed as
When tumors were 12±15 mm in diameter, the mice were anesthe-
the percentage inhibition of BCE growth in culture.
tized with methoxyflurane. The tumors in one group of mice were
surgically excised and the area closed with metal wound clips. The
Gelatin Zymographyother group underwent a sham surgical procedure, which left the
Aliquots of conditioned medium were subjected to electrophoresissubcutaneous tumors intact. The mice were monitored daily and
in a 7.5% polyacrylamide slab gel impregnated with 2 mg/ml gelatinkilled 10±14 days after surgery. The lungs were weighed and fixed
(Sigma). The gel was washed for 30 min at room temperature inin Bouin's solution. The tumor nodules were counted under a dis-
washing buffer (50 mM Tris-HCl (pH 7.5), 5 mM CaCl2, 1 mM ZnCl2,secting microscope.
2.5% Triton X-100), incubated for 24 hr at 378C with the washingIn another set of experiments, mice with 3LL-nm subcutaneous
buffer containing 1% Triton X-100, and stained with Coomassietumors 10±12 mm in diameter underwent resection of the lesion or
blue R250. The gelatinolytic activity was quantified by densitometricsham surgery. One day later, the two groups (n 5 10) received 1 3
scanning (Molecular Dynamics, Sunnyvale, CA) (Xie et al., 1994).105 3LL-met cells intravenously. Three weeks later, the mice were
killed and metastases were evaluated as described above.
RNA Isolation and Northern Blot Analyses
The mRNA was extracted from tumor tissue or cell cultures usingCollection and Cultivation of Mouse Peritoneal Macrophages
the Fast-Track kit (Invitrogen, San Diego, CA). One microgram ofMouse peritoneal macrophages (PEM) were collected by peritoneal
mRNA was fractionated in 1% denaturing formaldehyde/agaroselavage with HBSS from mice given an intraperitoneal injection of
gels, electrotransferred to GeneScreen nylon membrane (DuPont,1.5 ml of thioglycollate broth 4 days previously. The PEM were plated
Boston, MA), and ultraviolet± cross-linked with 120,000 mJ/cm2 us-onto 24-well dishes at a density of 2 3 105 cells/well. After 2 hr, the
ing a UV Stratalinker 1800 (Stratagene, La Jolla, CA). Hybridizationadherent cultures were washed. The resultant PEM population was
was performed as previously described (Dong et al., 1995). Themore than 98% pure according to morphologic and phagocytic
filters were washed at 508C±608C with 30 mM NaCl/3 mM sodiumcriteria (Dong et al., 1993).
citrate (pH 7.2)/0.1% SDS. The probes used were cDNA fragments
corresponding to rat glyceraldehyde-3-phosphate dehydrogenaseSample Preparations
(GAPDH) (Dong et al., 1994), MMP-2 (American Type Culture Collec-Tumor Cell Conditioned Medium
tion, Rockville, MD), MMP-9 (Levy et al., 1991), and MME (ShapiroAdherent cultures of tumor cells were given MEM±5% FBS and
et al., 1992). mRNA expression was quantified on an LKB Ultrascangrown for 96 hr. Cell-free supernatant was prepared, aliquoted, and
XL laser densitometer (Pharmacia LKB Biotechnology, Uppsala,stored at 2808C until use.
Sweden). Each sample measurement was calculated as the ratio ofElastase and Angiostatin
the average area of the proteinase transcripts to that of the GAPDHPEM were incubated for 24 hr with tumor cells (2 3 105cells/well) or
transcript.with tumor cell±conditioned medium in MEM±5% FBS. The cultures
were washed, and the cells were incubated in 0.5 ml serum-free
DMEM-F12 medium (for the elastase assay) or medium containing RT-PCR Analysis for GM-CSF Gene Expression
RNA from tumor tissues or cell cultures was reverse transcribed100±200 mg/ml plasminogen for 72 hr (for the angiostatin activity
assay). The medium was collected and centrifuged at 3000 3 g at using an avian myoblastosisvirus reverse transcriptase system (Pro-
mega, Madison, WI). The resulting cDNA from 20 ng mRNA was48C for 30 min. The supernatants were used in the assays as de-
scribed below. amplified for 25 cycles (1 cycle: 948C, 45 s; 608C, 45 s; and 728C, 1
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min) using a PCR system (Promega) containing a 200 nM concentra- Busiek, D.F., Ross, P., McDonnell, S., Murphy, G., Matrisian, L.M.,
and Welgus, H.G. (1992). The matrix metalloprotease matrilysintion of each primer (GM-CSF: CCC ATC ACT GTC ACC CGG CCT
TGG and GTC CGT TTC CGG AGT TGG GGG GC, defining a 279 (PUMP) is expressed in developing human mononuclear phago-
cytes. J. Biol. Chem. 267, 9087±9092.bp fragment; b-actin: GTG GGC CGC TCT AGG CAC CA and CGG
TTG GCC TTA GGG GTC AGG CTG G, defining a 245 bp fragment Dong, Z., Qi, X., and Fidler, I.J. (1993). Tyrosine phosphorylation of
[Strategene]). MAP kinase is necessary for activation of murine macrophages by
natural and synthetic bacterial products. J. Exp. Med. 173, 1071±
Western Blot Analysis 1077.
Samples isolated from culture supernatants were mixed with sample
Dong, Z., Radinsky, R., Fan, D., Tsan, R., Bucana, C.D., Wilmanns,
buffer (62.5 mM Tris/HCl (pH 6.8), 2.3% SDS, 100 mM dithiothreitol, C., and Fidler, I.J. (1994). Organ-specific modulation of steady-state
and 0.05% bromophenol blue), boiled, and separated on 10% SDS mdr gene expression and drug resistance in murine colon cancer
polyacrylamide gel electrophoresis. The protein was transferred cells. J. Natl. Cancer Inst. 86, 913±920.
onto 0.45 mm nitrocellulose membranes. The filter was blocked with
Dong, Z., Yang, X., Xie, K., Juang, S., Llansa, N., and Fidler, I.J.3% bovine serum albumin in Tris-buffered saline (20 mM Tris/HCl
(1995). Activation of inducible nitric oxide synthase gene in murine(pH 7.5), 150 mM NaCl), probed with antibody against LBS-1 (1 mg/
macrophages requires protein phosphatases-1 and 2-A activities.ml) in Tris-buffered saline containing 0.1% Tween 20, incubated
J. Leukoc. Biol. 58, 725±732.with a second antibody in the buffer, and visualized by the enhanced
Fidler, I.J. (1985). Macrophages and metastasis: a biological ap-chemiluminescence Western blotting detection system (Dong et al.,
proach to cancer therapy. Cancer Res. 45, 4714±4726.1993).
Fidler, I.J. (1990). Critical factors in the biology of human cancer
Chromatographic Analysis metastasis: twenty-eighth G. H. A. Clowes memorial award lecture.
Samples of macrophage-conditioned medium plus human plasmin- Cancer Res. 50, 6130±6138.
ogen were concentrated (SpeedVac concentrator, Savant Instru- Fidler, I.J. (1994). Therapy of cancer metastasis by systemic activa-
ments, Farmingdale, NY) and fractionated using a Superdex-200 tion of macrophages. Adv. Pharmacol. 30, 271±326.
column in an FPLC system (Pharmacia LKB). The eluates (in PBS)
Fidler, I.J. (1995). Modulation of the organ microenvironment for thewere dialyzed against DMEM and assessed for angiostatin activity
treatment of cancer metastasis [commentary]. J. Natl. Cancer Inst.or analyzed by Western blotting using anti-LBS-1 antibody.
87, 1588±1592.
Fidler, I.J., and Ellis, L.M. (1994). The implications of angiogenesisStatistics
for the biology and therapy of cancer metastasis. Cell 79, 185±188.The significance of the in vitro data was analyzed by the Student's
t test (two-tailed). Differences in the numbers and sizes of lung Fidler, I.J., and Schroit, A.J. (1988). Recognition and destruction of
metastases between groups were compared by the Mann-Whitney neoplastic cells by activated macrophages: discrimination of altered
U test. self. Biochim. Biophys. Acta 948, 151±173.
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